Mark Wildgust, vice president of global medical affairs for J&J’s oncology division, shares strategies for making clinical trials gender- and trans-inclusive.
Mark Wildgust, vice president of global medical affairs for J&J’s oncology division, shares strategies for making clinical trials gender- and trans-inclusive.
Copyright © 2024 | WordPress Theme by MH Themes